Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

PubMed  Google Scholar 

Khuntia D, Reddy CA, Mahadevan A, Klein EA, Kupelian PA (2004) Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect? Cancer 100(6):1283–1292

Article  PubMed  Google Scholar 

Ceci F, Herrmann K, Castellucci P, Graziani T, Bluemel C, Schiavina R et al (2014) Impact of (11)C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial. Eur J Nucl Med Mol Imaging 41(12):2222–2231

Article  PubMed  Google Scholar 

Hövels AM, Heesakkers RAM, Adang EM, Jager GJ, Strum S, Hoogeveen YL et al (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63(4):387–395

Article  PubMed  Google Scholar 

Afshar-Oromieh A, Zechmann CM, Malcher A, Eder M, Eisenhut M, Linhart HG et al (2014) Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging 41(1):11–20

Article  CAS  PubMed  Google Scholar 

Kratochwil C, Giesel FL, Stefanova M, Benešová M, Bronzel M, Afshar-Oromieh A, Mier W, Eder M, Kopka K, Haberkorn U (2016) PSMA-Targeted radionuclide therapy of metastatic Castration-Resistant prostate Cancer with 177Lu-Labeled PSMA-617. J Nucl Med 57(8):1170–1176

Article  CAS  PubMed  Google Scholar 

Dietlein M, Kobe C, Kuhnert G, Stockter S, Fischer T, Schomäcker K, Schmidt M, Dietlein F, Zlatopolskiy BD, Krapf P, Richarz R, Neubauer S, Drzezga A, Neumaier B (2015) Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET imaging in patients with relapsed prostate Cancer. Mol Imaging Biol 17(4):575–584

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giesel FL, Hadaschik B, Cardinale J, Radtke J, Vinsensia M, Lehnert W et al (2017) F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. Eur J Nucl Med Mol Imaging 44(4):678–688

Article  CAS  PubMed  Google Scholar 

Mease RC, Dusich CL, Foss CA, Ravert HT, Dannals RF, Seidel J et al (2008) N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L- cysteine, [18F]DCFBC: A new imaging probe for prostate cancer. Clin Cancer Res 14(10):3036–3043

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giglio J, Zeni M, Savio E, Engler H (2018) Synthesis of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform. EJNMMI Radiopharm Chem 3(1):4

Article  PubMed  PubMed Central  Google Scholar 

Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, Giesel F, Haberkorn U, Hope TA, Kopka K, Krause BJ, Mottaghy FM, Schöder H, Sunderland J, Wan S, Wester HJ, Fanti S, Herrmann K (2017) 68Ga-PSMA PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging 44(6):1014–1024

Article  PubMed  Google Scholar 

Georgakopoulos A, Bamias A, Chatziioannou S (2023) Current role of PSMA-PET imaging in the clinical management of prostate cancer. Ther Adv Med Oncol 15:17588359231208960

Article  PubMed  PubMed Central  Google Scholar 

Souvatzoglou M, Eiber M, Martinez-Moeller A, Fürst S, Holzapfel K, Maurer T et al (2013) PET/MR in prostate cancer: Technical aspects and potential diagnostic value. Eur J Nucl Med Mol Imaging.;40(SUPPL. 1)

Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA et al (2013) Pet imaging with a [68ga]gallium-labelled Psma ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging 40(4):486–495

Article  CAS  PubMed  Google Scholar 

Giesel FL, Will L, Lawal I, Lengana T, Kratochwil C, Vorster M et al (2018) Intraindividual comparison of 18 F-PSMA-1007 and 18 FDCFPyL PET/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: A pilot study. J Nucl Med 59(7):1076–1080

Article  CAS  PubMed  Google Scholar 

Afshar-Oromieh A, Avtzi E, Giesel FL et al (2015) The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging 42:197–209

Article  CAS  PubMed  Google Scholar 

Eiber M, Maurer T, Souvatzoglou M, Beer AJ et al (2015) Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med 56(5):668–674

Article  PubMed  Google Scholar 

Alonso O, dos Santos G, García Fontes M, Balter H, Engler H (2018) 68Ga-PSMA and 11 C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle. Eur J Hybrid Imaging.;2(1)

Eiber M, Fendler WP, Rowe SP, Calais J, Hofman MS, Maurer T et al (2017) Prostate-specific membrane antigen ligands for imaging and therapy. Journal of Nuclear Medicine, vol 58. Society of Nuclear Medicine Inc., pp 67S–76S

Chen Y, Pullambhatla M, Foss CA, Byun Y, Nimmagadda S, Senthamizhchelvan S et al (2011) 2-(3--ureido)-pentanedioic acid, [ 18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer. Clin Cancer Res 17(24):7645–7653

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lütje S, Franssen GM, Herrmann K, Boerman OC, Rijpkema M, Gotthardt M, Heskamp S (2019) In vitro and in vivo characterization of an 18F-AlF-Labeled PSMA ligand for imaging of PSMA-Expressing xenografts. J Nucl Med 60(7):1017–1022

Article  PubMed  Google Scholar 

Ioppolo JA, Nezich RA, Richardson KL, Morandeau L, Leedman PJ, Price RI (2020) Direct in vivo comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 and [18F]AlF-PSMA-11 in mice bearing PSMA-expressing xenografts. Appl Radiat Isot 161:109164

Article  CAS  PubMed  Google Scholar 

Yu C, Pan D, Mi B, Xu Y, Lang L, Niu G et al (2015) 18 F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases. Eur J Nucl Med Mol Imaging 42(13):2021–2028

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boschi S, Lee JT, Beykan S, Slavik R, Wei L, Spick C et al (2016) Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand. Eur J Nucl Med Mol Imaging 43(12):2122–2130

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allott L, Da Pieve C, Turton DR, Smith G (2017) A general [18F]AlF radiochemistry procedure on two automated synthesis platforms. React Chem Eng 2(1):68–74

Article  CAS  Google Scholar 

EJNMMI Rep (2024) 8(1): 28. https://doi.org/10.1186/s41824-024-00217-5

Maurer T, Gschwend JE, Rauscher I, Souvatzoglou M, Haller B, Weirich G et al (2016) Diagnostic efficacy of 68Gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer. J Urol 195(5):1436–1443

Article  PubMed  Google Scholar 

Chakraborty PS, Tripathi M, Agarwal KK, Kumar R, Vijay MK, Bal C (2015) Metastatic poorly differentiated prostatic carcinoma with neuroendocrine differentiation. Clin Nucl Med 40(2):e163–e166

Article  PubMed  Google Scholar 

Hoffmann MA, Miederer M, Wieler HJ, Ruf C, Jakobs FM, Schreckenberger M (2017) Diagnostic performance of 68Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with 18FEC PET/CT. Oncotarget 8(67):111073–111083

Article  PubMed  PubMed Central  Google Scholar 

Perera M, Papa N, Christidis D, Wetherell D, Hofman MS, Murphy DG, Bolton D, Lawrentschuk N (2016) Sensitivity, specificity, and predictors of positive 68Ga-Prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: A systematic review and Meta-analysis. Eur Urol 70(6):926–937

Article  PubMed  Google Scholar 

Berliner C (2017) Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [68Ga]PSMA I&T and comparison with published data of [68Ga]PSMA HBED-CC. Eur J Nucl Med Mol Imaging 44:670–677

Article  CAS  PubMed  Google Scholar 

Haffner MC, Kronberger IE, Ross JS, Sheehan CE, Zitt M, Mühlmann G, Ofner D, Zelger B, Ensinger C, Yang XJ, Geley S, Margreiter R, Bander NH (2009) Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol 40(12):1754–1761

Article  CAS  PubMed  Google Scholar 

Jochumsen MR, Dias AH, Bouchelouche K (2018) Benign traumatic rib fracture. Clin Nucl Med 43(1):38–40

Article  PubMed